Found 7 matching trials
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma PHASE2 This is a global phase II, open label study in the subjects with Advanced H...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
PF-03446962 in Relapsed or Refractory Urothelial Cancer PHASE2 Salvage chemotherapy for advanced urothelial cancer (UC) yields suboptimal ...
Show More Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Learn More & Join Trial
A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer PHASE2 The primary purpose of the study is to explore whether treatment with PF-03...
Show More Location
Fox Chase Cancer Center
Learn More & Join Trial
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma PHASE2 This is a non-randomized open label multicentre Phase II trial to evaluate ...
Show More Location
Cross Cancer Institute
Learn More & Join Trial
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors PHASE1 The purpose of this study is to test the safety and effectiveness of PF-034...
Show More Location
Fox Chase Cancer Center
Learn More & Join Trial
Asian Phase I Study Of PF-03446962 PHASE1 This is an Asian Phase 1, multi center, open label, single arm study of PF ...
Show More Location
National Cancer Center Hospital East
Learn More & Join Trial
Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer PHASE1 The primary objective of this open-label phase Ib trial is to determine the...
Show More Location
Duke Cancer Center, Duke University Medical Center
Learn More & Join Trial